论文部分内容阅读
根据白血病细胞核仁组成区银染（ＡｇＮＯＲ）法体外药敏试验结果，选用化疗药物治疗２８例急性白血病，完全缓解１６例，部分缓解５例，未缓解７例，总有效率为７５％。体外药敏与临床疗效阳性符合率为８４％，阴性符合率为１００％，总符合率为８５．７％，与国内既往报道的３Ｈ－ＴｄＲ掺入法和ＭＴＴ法敏感试验结果一致，但本法简便易行，耗时少，是指导临床择优选择化疗方案的一种有效手段。
According to the results of in vitro drug susceptibility test of silver staining (AgNOR) method in leukemia cells, 28 patients with acute leukemia were treated with chemotherapeutic drugs. Complete remission was achieved in 16 patients, partial remission in 5 patients, and no remission in 7 patients. The total effective rate was 75%. The positive coincidence rate of drug susceptibility and clinical efficacy in vitro was 84%, the negative coincidence rate was 100%, and the overall compliance rate was 85.7%. This was in line with the previous 3H-TdR incorporation method and MTT sensitivity test results reported in China. The method is simple, easy, and time-consuming, and it is an effective method to guide the clinical selection of chemotherapy options.